The Director,CMC Regulatory Affairs is responsible for content development, compilation, maintenance, and review of the Quality Module for regulatory submissions to support Celularity drug products including, DMF, IND and NDA/BLA applications, Health Authority (HA) responses, and briefing packages (including participating in/leading CMC-specific HA meetings). The individual also performs regulatory assessments of proposed manufacturing changes and provides guidance on CMC regulatory expectations throughout development.
The individual functions as the Regulatory CMC lead on assigned project and submission teams by applying advanced knowledge of regulations and interpreting technical regulatory guidelines to ensure regulatory submissions are in compliance with applicable guidances and regulations.
This key role requires CMC regulatory expertise through all stages of a product's lifecycle, preferably in cellular therapies and involves development of regulatory CMC strategies. This role builds and relies on critical partnerships with key stakeholders to execute the strategies in alignment with business priorities.
Software Powered by iCIMS
www.icims.com